Press Releases                                              

Hewlett Packard's (NYSE: HPQ) Hit Improves IBM's (NYSE: IBM) Chart
Shares of Hewlett Packard's (NYSE: HPQ) failed to recover meaningfully on Monday, but IBM's (NYSE: IBM) chart showed some improvement.



Chart Courtesy of StockCharts.com


IBM is a forgotten giant. But it was using a good portion of Hewlett Packard's business model a long time ago, and making money with it, consulting and integrating the technology components of the enterprise. IBM also has a financing arm which lets the company's clients internally finance their business solutions.

IBM also makes hardware and software, and provides integration services. IBM's been doing this stuff since 1911 and has a huge global footprint. Its problem is that it's not a big growth story, given its maturity and the huge number of competitors that it battles, including HPQ, as well as Oracle and others.

Still, it's easy to own IBM is you're a mutual fund manager looking to own big tech. You don't have to ask too many questions, as clients aren't going to penalize you for owning a stalwart stock like IBM, regardless of its lack of growth. It pays a dividend, which is important these days.

Plus, it's got all the stuff that value managers like going for it; a P/E ratio of 12, huge margins, cash flow, and an insane 66% return on equity, which measures management's efficacy.

So what's not to like? Owning IBM is like owning the biggest aircraft carrier in the world. It's safe enough, but it's not very maneuverable.

Of course, unless something changes, it doesn't have a big management problem either. And given the weak bounce in HPQ on Monday, the market may be thinking that other shoes could drop in HPQ, making IBM interesting, even if it's not all that sexy.

Follow Dr. Duarte on Twitter

Make money if any market rises or falls, with a copy of "Market Timing For Dummies."

“Futures And Options For Dummies,” Dr. Duarte’s latest book is now available. The markets are responding to news and geopolitical developments like never before. In this environment, individual investors need to expand their investment horizons. "Futures And Options For Dummies " (John Wiley & Sons) has an excellent section on oil futures as well as the currency markets, while covering and expanding on the successful strategies in Doctor Duarte's other books. Order your copy today.

Doctor Joe Duarte's Market I.Q., offers subscribers a unique blend of intelligence, market commentary and trading strategy. Duarte's daily articles, and news summaries offer recommendations and analysis for ETFs, and individual stocks in the technology, health and biotechnology, and energy sectors. Doctor Duarte is a writer, and an emerging futurist, with a diverse background, and a growing audience. His combined expertise in health care, energy, and the effects of politics and global intelligence on the financial markets offer a unique blend of insight and information to thousands of active investors and political and intelligence aficionados around the world on a daily basis.

He is the author of four books: "Futures And Options For Dummies," "Successful Energy Sector Investing," "Successful Biotech Investing" and co-author of "After-Hours Trading Made Easy."

In early 2001 Dr. Duarte in "Successful Energy Sector Investing," correctly predicted that Venezuela's political problems could lead to an energy crisis in the United States.

In 2003, also Dr. Duarte was among the first to widely publicize the long-term friendship between French President Jacques Chirac and Saddam Hussein.

He has also appeared as a weekly guest on Market Mavens Radio, has logged appearances on KNX radio in Los Angeles, Financial Sense.com radio, and Wall Street Radio.

One of CNBC's original Market Mavens, Dr. Duarte has been writing about the financial markets since 1990.

His articles and commentary have been featured on CBS Marketwatch, Barron's, Smart Money, Medical Economics, and in Technical Analysis of Stocks and Commodities magazines.

In 2003, Doctor Duarte received second place, in the professional section, of the Medical Economics Investment Challenge with a 12-month return of 42%.




Joe-Duarte.com is independently operated and solely funded by subscriber fees. This web site and the content provided is meant for educational purposes only and is not a solicitation to buy or sell any securities or investments. All sources of information are believed to be accurate, or as otherwise stated. Dr. Duarte and the publishers, partners, and staff of Joe-Duarte.com have no financial interest in any of the sources used. For independent investment advice consult your financial advisor. The analysis and conclusions reached on Joe-Duarte.com are the sole property of Dr. Joe Duarte.